Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dipna PharmachemBOM:543594 +9.64%62 PB Ratio is 0.21 as of Aug. 08, 2026, which is 74% below its 10-year median of 0.81. GuruFocus rates BOM:543594 with a GF Score™ of 62/100 and a GF Value™ of ₹9.16 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 609 Healthcare Providers & Services companies, Dipna Pharmachem ranks better than 98.52% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-08), Dipna Pharmachem's share price is ₹4.89. Dipna Pharmachem's Book Value per Share for the quarter that ended in Mar. 2026 was ₹23.70. Hence, Dipna Pharmachem's PB Ratio of today is 0.21.
Good Sign:
Dipna Pharmachem Ltd stock PB Ratio (=0.21) is close to 5-year low of 0.21.
The historical rank and industry rank for Dipna Pharmachem's PB Ratio or its related term are showing as below:
BOM:543594'
s PB Ratio Range Over the Past 10 Years
Min: 0.18 Med: 0.81 Max: 21.87
Current: 0.23
During the past 7 years, Dipna Pharmachem's highest PB Ratio was 21.87. The lowest was 0.18. And the median was 0.81.
BOM:543594's PB Ratio is ranked better than 98.52% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 2.05
vs BOM:543594: 0.23
During the past 12 months, Dipna Pharmachem's average Book Value Per Share Growth Rate was 48.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 12.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 124.00% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Dipna Pharmachem was 254.30% per year. The lowest was 12.30% per year. And the median was 189.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Dipna Pharmachem PB Ratio Related Terms
Dipna Pharmachem PB Ratio Historical Data
* Premium members only.
The historical data trend for Dipna Pharmachem's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dipna Pharmachem PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's PB Ratio distribution charts can be found below:
* The bar in red indicates where Dipna Pharmachem's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Dipna Pharmachem (BOM:543594) has a PB Ratio of 0.21 as of Aug. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dipna Pharmachem and its competitors. This is 74% below median its historical median of 0.81. Over the past decade, Dipna Pharmachem's PB Ratio has ranged from 0.18 to 21.87. According to the industry distribution chart, Dipna Pharmachem ranks #9 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 1.5%.
Is Dipna Pharmachem's PB Ratio too high?
Dipna Pharmachem's current PB Ratio of 0.21 is 74% below median its 10-year median of 0.81. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 21.87. The Healthcare Providers & Services industry median PB Ratio is 2.05. Dipna Pharmachem's value of 0.21 is 89.8% below this industry median. Based on the distribution chart, Dipna Pharmachem ranks #9 out of 609 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dipna Pharmachem has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dipna Pharmachem's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dipna Pharmachem ranks #9 out of 609 companies for PB Ratio. This places Dipna Pharmachem in the top 2% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.05. Dipna Pharmachem's value of 0.21 is 89.8% below this benchmark. Historically, Dipna Pharmachem's own PB Ratio has ranged from 0.18 to 21.87 over the past decade. While the company's 10-year median is 0.81 vs. the industry median of 2.05, Dipna Pharmachem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.05, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dipna Pharmachem's current PB Ratio of 0.21 is 89.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dipna Pharmachem and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dipna Pharmachem's current PB Ratio is 0.21, which is 74% below median its own 10-year median of 0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dipna Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Dipna Pharmachem (BOM:543594) is currently considered Possible Value Trap. The stock's GF Value™ is ₹9.16, compared to a current price of ₹4.89 — trading 46.6% below its estimated fair value. The current PB Ratio is 0.21, which is 74% below median its 10-year median of 0.81 and 89.8% below the Healthcare Providers & Services industry median of 2.05. Dipna Pharmachem's overall GF Score™ is 62/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Dipna Pharmachem (BOM:543594), the current PB Ratio is 0.21 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dipna Pharmachem (BOM:543594) Overvalued in 2026?
Based on GuruFocus' analysis, Dipna Pharmachem stock appears to be undervalued.
The current stock price of ₹4.89 is trading 46.6% below its estimated GF Value™ of ₹9.16.
GuruFocus considers Dipna Pharmachem to be Possible Value Trap.
Key valuation signals for BOM:543594:
PB Ratio: 0.21 (74% below median its 10-year median of 0.81)
GF Value™: ₹9.16 vs. price of ₹4.89 (46.6% below fair value)
Industry Position: 89.8% below the Healthcare Providers & Services median (#9 of 609)
No single metric tells the full story. See the BOM:543594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.
62GF Score
Get the complete analysis for BOM:543594
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543594 has been successfully added to your 
